Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2003
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003065992A2 Treating benign prostate hyperplasia with sarms
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002043714A3 Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002015933A3 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030153755 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
08/14/2003US20030153621 Administering mixtures of 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE) and carriers comprising glycerides or fatty esters as controllers of endothelial growth factors
08/14/2003US20030153605 Enzyme inhibitors of nitric oxide synthase
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153557 Treating osteoporosis, cardiovascular disorders, restenosis, arteriosclerosis, nephropathies or retinopathies; antitumor and antiinflammatory agents
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153536 Compounds and methods of treating transplant rejection
08/14/2003US20030153500 Use of EGF to inhibit pathogenic infections
08/14/2003US20030153075 TGF-beta-specific covalently closed antisense molecule
08/14/2003US20030153073 Expansion of T cells in vitro and expanded T cell populations
08/14/2003US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152624 Controlled release dosage form having improved drug release properties
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475108A1 Treating benign prostate hyperplasia with sarms
08/14/2003CA2475093A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/14/2003CA2471964A1 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
08/13/2003EP1334973A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
08/13/2003EP1334972A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH)
08/13/2003EP1334723A1 Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2- 2- 4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient
08/13/2003EP1334367A2 A method of determining the initial dose of vitamin d compounds
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334120A2 Modified clostridial neurotoxins with altered biological persistence
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1333887A2 Combination therapy comprising anti-diabetic and anticonvulsant agents
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0879233B1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436173A Hydroxy formamidine derivs. and medicines contg. same
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/13/2003CN1436047A Compositions and methods for improving vascular health
08/13/2003CN1435247A Chinese medicine preparation for treating lithiasis in urinary system and urethral infection, and preparing method thereof
08/13/2003CN1435218A Medicine for treating stranguria
08/13/2003CN1435183A Cell growth regulatory factor L and preparing process thereof
08/13/2003CN1117738C Endothelin antagonists
08/13/2003CN1117528C Nutritional product for person having renal failure
08/12/2003US6605642 Inhibitors of formation of advanced glycation endproducts (AGES)
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605612 Cardioprotective phosohonates and malonates
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
08/12/2003US6605600 Diuretics
08/12/2003US6605593 Enhanced efficacy and reduced toxicity
08/12/2003US6605592 Protein HOFNF53
08/12/2003CA2418712A1 Non-peptide gnrh agents, pharmaceutical compositions, and methods for their use
08/12/2003CA2277473C Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064646A1 Novel peptide and use thereof
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064448A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064443A2 New corticosteroids
08/07/2003WO2003064429A1 Thienopyrimidines, process for preparing the same and use thereof
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064419A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/07/2003WO2003064418A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
08/07/2003WO2003064417A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
08/07/2003WO2003064398A1 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
08/07/2003WO2003064389A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 562